The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Transitioning adriamycin ifosfamide mesna (AIM) chemotherapy in sarcoma patients to the outpatient setting: Evaluation of outpatient chemotherapy in an oncology care model setting.
 
Cindy Banh
No Relationships to Disclose
 
Kendall Valsvik
No Relationships to Disclose
 
Alejandra Arredondo
No Relationships to Disclose
 
Kassie Notbohm
No Relationships to Disclose
 
Abhijeet Kumar
No Relationships to Disclose
 
Lee D. Cranmer
Consulting or Advisory Role - Blueprint Medicines; Daiichi Sankyo; Regeneron
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); CBA Research (Inst); Exelixis (Inst); Iterion Therapeutics (Inst); Lilly (Inst); Philogen (Inst)
 
Andrew S. Kraft
No Relationships to Disclose
 
Ivo Abraham
Consulting or Advisory Role - Celgene (Inst); Coherus Biosciences (Inst); Janssen Scientific Affairs (Inst); Novartis (Inst); Rockwell Medical (Inst); Sandoz (Inst); TERUMO (Inst)
Speakers' Bureau - Coherus Biosciences (Inst)
 
Ali McBride
Speakers' Bureau - Coherus BioSciences